Lipum AB Cash Flow Conversion Efficiency

Latest as of December 2025: 1.465x

Lipum AB cash flow conversion efficiency. Based on the latest financial reports, Lipum AB (LIPUM) has a cash flow conversion efficiency ratio of 1.465x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-6.95 Million ≈ $-747.82K USD) by net assets (Skr-4.74 Million ≈ $-510.31K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Lipum AB (2018–2025)

Cash flow conversion efficiency of Lipum AB from 2018 to 2025. This chart illustrates how Lipum AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. View LIPUM stock price for real-time trading data and today's change.

Lipum AB Cash Flow Conversion Ratio Explained

Lipum AB cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Lipum AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Lipum AB ranked by their cash flow conversion efficiency. Also see Lipum AB stock valuation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Phaos Technology Holdings (Cayman) Limited NYSE MKT:POAS	N/A
Vishnu Prakash R Punglia Limited NSE:VPRPL	0.089x
Qmines Ltd AU:QML	-0.145x
Laird Superfood Inc NYSE MKT:LSF	0.006x
Largo Resources Ltd TO:LGO	-0.092x
Aeries Technology Inc. NASDAQ:AERT	-1.835x
Sheh Kai Precision Co Ltd TWO:2063	0.067x
Laser Photonics Corporation Common Stock NASDAQ:LASE	3.174x

Annual Cash Flow Conversion Efficiency for Lipum AB (2018–2025)

The table below shows the annual cash flow conversion efficiency of Lipum AB from 2018 to 2025. Review Lipum AB financial flexibility index to assess the company's free cash flow relative to its total liabilities.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr-4.74 Million ≈ $-510.31K	Skr-34.94 Million ≈ $-3.76 Million	7.368x	+287.28%
2024-12-31	Skr22.00 Million ≈ $2.37 Million	Skr-86.53 Million ≈ $-9.31 Million	-3.934x	+50.21%
2023-12-31	Skr4.57 Million ≈ $492.02K	Skr-36.13 Million ≈ $-3.89 Million	-7.902x	-322.88%
2022-12-31	Skr28.05 Million ≈ $3.02 Million	Skr-52.41 Million ≈ $-5.64 Million	-1.869x	-51.90%
2021-12-31	Skr27.88 Million ≈ $3.00 Million	Skr-34.30 Million ≈ $-3.69 Million	-1.230x	+79.51%
2020-12-31	Skr3.23 Million ≈ $347.31K	Skr-19.37 Million ≈ $-2.08 Million	-6.002x	-391.71%
2019-12-31	Skr15.87 Million ≈ $1.71 Million	Skr-19.37 Million ≈ $-2.08 Million	-1.221x	+98.83%
2018-12-31	Skr185.26K ≈ $19.94K	Skr-19.37 Million ≈ $-2.08 Million	-104.555x	--

About Lipum AB

ST:LIPUM Sweden Biotechnology

Market Cap

$32.76 Million

Skr304.40 Million SEK

Market Cap Rank

#23275 Global

#439 in Sweden

Share Price

Skr14.35

Change (1 day)

+0.70%

52-Week Range

Skr9.96 - Skr15.20

All Time High

Skr26.40